ZAGOTENEMAB

UNII:	AY6V5E2GNX
Formula:
Preferred Substance Name:	ZAGOTENEMAB
GSRS Full Record:	AY6V5E2GNX i

2019133-28-7
IMMUNOGLOBULIN G4, ANTI-(TAU PROTEIN) (HUMAN MONOCLONAL LY3303560 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LY3303560 LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS MICROTUBULE-ASSOCIATED PROTEIN TAU (NEUROFIBRILLARY TANGLE PROTEIN, PHF-TAU)) HUMANIZED MONOCLONAL ANTIBODY .GAMMA.4 HEAVY CHAIN (1-442) (HUMANIZED VH (HOMO SAPIENS IGHV5-51*01 (85%) (IGHD)-IGHJ4*01 (87%)) (8.8.9) (1-116) -HOMO SAPIENS IGHG4*01 (HINGE(S10>P(224)), CH2(F4>A(230),L5>A(231)), CH3(K107>DEL(443))) (117-442)) (130-219')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-219') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV3-20*01 (79%) IGKJ4*01)(11.3.9) (1'-112') -HOMO SAPIENS IGKC*01 (113'-219')), DIMER (222-222'':225-225'')-BISDISULFIDE
LY3303560
LY-3303560
ZAGOTENEMAB [INN]
ZAGOTENEMAB [USAN]
ZAGOTENEMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ZAGOTENEMAB

Synonyms and Mappings

Resources